S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
NASDAQ:INBS

Intelligent Bio Solutions - INBS Stock Forecast, Price & News

$0.82
-0.14 (-14.60%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.75
$0.88
50-Day Range
$0.19
$1.24
52-Week Range
$0.17
$1.60
Volume
2.05 million shs
Average Volume
9.52 million shs
Market Capitalization
$15.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

INBS stock logo

About Intelligent Bio Solutions (NASDAQ:INBS) Stock

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Stock News Headlines

Reviewing Intelligent Bio Solutions (INBS) and Its Peers
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Comparing Intelligent Bio Solutions (INBS) & The Competition
Intelligent Bio Solutions Inc Ordinary Shares
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
INBS: It’s Touch and Go From Here
See More Headlines
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Company Calendar

Today
1/29/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INBS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-8,310,000.00
Net Margins
-1,078.91%
Pretax Margin
-1,082.78%

Debt

Sales & Book Value

Annual Sales
$440,000.00
Book Value
$0.44 per share

Miscellaneous

Free Float
18,006,000
Market Cap
$15.03 million
Optionable
Not Optionable
Beta
1.47

Key Executives

  • Mr. Harry Simeonidis (Age 55)
    Pres & CEO
    Comp: $354.71k
  • Mr. Spiro Kevin Sakiris B.Bus (Age 60)
    C.A., CA, Dip Law, Chief Financial Officer
    Comp: $292.45k
  • Ms. Victoria Gavrilenko (Age 39)
    Operations Mang.
  • Mr. Alex Arzeno
    VP of Investor Relations













INBS Stock - Frequently Asked Questions

How have INBS shares performed in 2023?

Intelligent Bio Solutions' stock was trading at $0.1999 on January 1st, 2023. Since then, INBS stock has increased by 309.7% and is now trading at $0.8190.
View the best growth stocks for 2023 here
.

What is Intelligent Bio Solutions' stock symbol?

Intelligent Bio Solutions trades on the NASDAQ under the ticker symbol "INBS."

How do I buy shares of Intelligent Bio Solutions?

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intelligent Bio Solutions' stock price today?

One share of INBS stock can currently be purchased for approximately $0.82.

How much money does Intelligent Bio Solutions make?

Intelligent Bio Solutions (NASDAQ:INBS) has a market capitalization of $15.03 million and generates $440,000.00 in revenue each year. The company earns $-8,310,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis.

How can I contact Intelligent Bio Solutions?

Intelligent Bio Solutions' mailing address is 142 WEST 57TH ST FL11, NEW YORK NY, 10019. The official website for the company is gbs.inc. The company can be reached via phone at 646-828-8258 or via email at investor.relations@gbs.inc.

This page (NASDAQ:INBS) was last updated on 1/29/2023 by MarketBeat.com Staff